|Articles|November 1, 2022
Supplements and Featured Publications
- Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update
- Volume 28
- Issue 12
What do patients and health care providers still need to know about biosimilar medicines?
Plain Language Summary
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
2
Patients With CKD Are Less Likely to Receive Adjuvant Chemotherapy
3
Top 5 Most-Read Heart Failure Content of 2025
4
Overcoming Pain Points to Advance Bispecifics in the Community for Patients With Myeloma
5




































